Hoshi Iryo-Sanki (7634) Q3 2025 earnings summary

Executive summary

• Revenue for the nine months ended December 31, 2024, increased by 3.1% year-over-year to ¥10,971 million, while operating profit declined by 1.7% to ¥1,372 million and net profit attributable to shareholders fell by 3.0% to ¥964 million.

• The business prioritized stable supply of products and services, safety for stakeholders, and fulfillment of social responsibility in the medical, nursing, and welfare sectors.

Financial highlights

• Gross profit rose to ¥5,545 million from ¥5,329 million year-over-year, but operating profit decreased to ¥1,372 million from ¥1,396 million.

• Ordinary profit was ¥1,429 million, down 2.1% year-over-year, and EPS for the period was ¥309.28, compared to ¥319.19 in the prior year.

• Total assets increased to ¥23,579 million, and net assets rose to ¥18,213 million, with an equity ratio of 76.0%.

• Comprehensive income for the period was ¥1,059 million, down 19.3% year-over-year.

Outlook and guidance

• Full-year revenue is forecast at ¥15,000 million (up 1.5% year-over-year), with operating profit of ¥2,010 million (up 2.5%) and net profit attributable to shareholders of ¥1,420 million (up 1.9%).

• No changes have been made to the previously announced earnings forecast.